Across TCGA pan-cancer cohorts, IFNLR1 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of IFNLR1’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where IFNLR1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types IFNLR1 is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.
HNSC, BLCA, and KICH are the cancer types where IFNLR1 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IFNLR1 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.